A study was carried out to assess the effect of carnauba wax particle s u e on sustained release characteristics, the effect of drug loading on release and the kinetics of propranolol hydrochloride release from carnauba wax matrices.
INTRODUCTION
Carnauba wax is widely used as an additive in cosmetics, certain foods stuffs and pharmaceutical formulations. When carnauba wax is used alone or in combination with other ingredients it can form matrices that release drug by diffusion in a sustained release fashion [I-61. The mechanism of drug release fiom carnauba wax-based matrices seems to be affected by additional ingredients added to the matrix system. Tableted microcapsules of carnauba wax and beeswax have been shown to release drug in a prolonged manner according to first order kinetics [5] . In another study, a matrix system made from carnauba wax and Eudragit L released drug by a combination of a diffusionerosion mechanism [7] .
Therefore this study was aimed at assessing the effect of carnauba wax particle size on sustaining release characteristics, determining the effect of d rug loading on drug release and investigating the kinetics of drug release from carnauba wax matrices with respect to propranolol hydrochloride.
EXPERIMENTAL MATERIALS
Pharmaceutical Company, Harare, Zimbabwe) was used to evaluate the release characteristics of the matrices.
METHODS

Tablet Preparation
Carnauba wax flakes were pulverized using a mortar and a pestle. The resulting powder was sieved through a series of test sieves of varying mesh to yield ,the four particle size ranges namely:710-500 pm,500-355 pm, 355-250 pn, and 250 -180 p.m. Sieved wax powder was then dry mixed with the drug (propranolol hydrochloride). The carnauba waxpropranolol hydrochloride mixtures were directly compressed on a single punch manually operated Erweka tablet machine (Type EK 0, G.m.b.H, Germany) equipped with 9 mm flat faced punches. Tablets (200 mg) were prepared by manually compressing 200 mg of the one sample (carnauba waxd u g samples). The drug content ranged fiom 20 -40 % w/w while tablet strength range was 6 -6.5 kN.
Dissolution Studies
Dissolution evaluation was carried out using the Carnauba wax was the basic sustained release matrix material. It was supplied by Croda rotating basket as specified in the USP [8]. The Chemical Company (Harare, Zimbabwe).
dissolution medium was distilled water.
Propranolol hydrochloride (Varichem Analysis of the released drug was carried out *Author to whom correspondence may be addressed.
using a W-visible spectophotometer (Shimadzu, W 1601, Japan) at 307 nm.
RESULTS AND DISCUSSION
Student ttests were carried out on some of the data obtained. The results were evaluated at the 5 % significant level (p = 0.05). The calculated t values (b) and the statistical table's t-value (t,&) at the appropriate degrees of freedom were also considered.
The effect of particle size on drug release from camauba wax is summarised in figure 1. For the first 1.5 h matrices made from three particle size ranges (250 -355 pm, 355 -500 pm and 500 -710 pm) had comparable sustained release characteristics. After 1.5 h, matrices containing the 355-500 pm particle size range had inferior release relative to the other two matrices. These latter two matrices appear to have the same sustained release characteristics of approximately 4 h. However, the smaller particles (180 -250 pm) produced compacts that had superior sustained release characteristics compared to compacts made from the rest of the larger particles.
The effect of drug loading on release is shown in figure 2 . At high drug loading (40 % wlw) release was faster than at 20 % wlw. This was probably due to higher porosity of the matrix at high drug loading than at low drug loading. The summary of the release kinetics from matrices made of the various particle size ranges is recorded in table 1. The correlation coefficient serves as a good indicator of the mechanism that best explains drug release from the various matrices. The Higuchi mechanism or first order kinetics could explain drug release from the 180 -250 pm matrixes ( t d = 0.4 13, cab = 2.776, p = 0.05). Zero order kinetics seemed to play no role in the release mechanism from this particular size range (t 2 12.56). However, zero order kinetics, the Higuchi mechanism or first order kinetics could explain drug release from the 250 -355 pm and 500 -710 pm matrices (b 5 0.939, I 1.668, respectively).
The Higuchi mechanism best explained drug release from compacts made from the 355 -500 pm particle size range (h 2 3.948).
CONCLUSION
Small particles (1 80 -250 pm) of carnauba wax produced matrices that had the best drug release sustaining characteristics.
The Higuchi mechanism or first order kinetics could be responsible for drug release from such matrices. In general, as particle size increases, zero order kinetics seems to play a role in the drug release mechanism. Increasing drug loading in carnauba wax matrices increases release rate probably due to high porosity.
